DK1568709T3 - Oprensning af fibrinogen - Google Patents

Oprensning af fibrinogen

Info

Publication number
DK1568709T3
DK1568709T3 DK05003017.0T DK05003017T DK1568709T3 DK 1568709 T3 DK1568709 T3 DK 1568709T3 DK 05003017 T DK05003017 T DK 05003017T DK 1568709 T3 DK1568709 T3 DK 1568709T3
Authority
DK
Denmark
Prior art keywords
fibrinogen
purification
negative
gel
vulnerary
Prior art date
Application number
DK05003017.0T
Other languages
English (en)
Inventor
Hubert Metzner
Uwe Liebing
Annette Feussner
Joerg Lemmer
Stefan Schulte
Volker Gawantka
Original Assignee
Csl Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Behring Gmbh filed Critical Csl Behring Gmbh
Application granted granted Critical
Publication of DK1568709T3 publication Critical patent/DK1568709T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C3/00—Dental tools or instruments
    • A61C3/06—Tooth grinding or polishing discs; Holders therefor
    • A—HUMAN NECESSITIES
    • A46—BRUSHWARE
    • A46B—BRUSHES
    • A46B15/00—Other brushes; Brushes with additional arrangements
    • A46B15/0002—Arrangements for enhancing monitoring or controlling the brushing process
    • A46B15/0016—Arrangements for enhancing monitoring or controlling the brushing process with enhancing means
    • A46B15/0032—Arrangements for enhancing monitoring or controlling the brushing process with enhancing means with protrusion for polishing teeth
    • A—HUMAN NECESSITIES
    • A46—BRUSHWARE
    • A46B—BRUSHES
    • A46B7/00—Bristle carriers arranged in the brush body
    • A46B7/04—Bristle carriers arranged in the brush body interchangeably removable bristle carriers
    • A—HUMAN NECESSITIES
    • A46—BRUSHWARE
    • A46B—BRUSHES
    • A46B9/00—Arrangements of the bristles in the brush body
    • A46B9/02—Position or arrangement of bristles in relation to surface of the brush body, e.g. inclined, in rows, in groups
    • A46B9/04—Arranged like in or for toothbrushes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A46—BRUSHWARE
    • A46B—BRUSHES
    • A46B2200/00—Brushes characterized by their functions, uses or applications
    • A46B2200/10—For human or animal care
    • A46B2200/1066—Toothbrush for cleaning the teeth or dentures

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Dentistry (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DK05003017.0T 2004-02-24 2005-02-12 Oprensning af fibrinogen DK1568709T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004009400A DE102004009400A1 (de) 2004-02-24 2004-02-24 Fibrinogen Reinigung

Publications (1)

Publication Number Publication Date
DK1568709T3 true DK1568709T3 (da) 2011-08-22

Family

ID=34745287

Family Applications (3)

Application Number Title Priority Date Filing Date
DK10183940.5T DK2267025T3 (da) 2004-02-24 2005-02-12 Rensning af fibrinogen
DK05003017.0T DK1568709T3 (da) 2004-02-24 2005-02-12 Oprensning af fibrinogen
DK10182320.1T DK2264069T3 (da) 2004-02-24 2005-02-12 Rensning af fibrinogen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK10183940.5T DK2267025T3 (da) 2004-02-24 2005-02-12 Rensning af fibrinogen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK10182320.1T DK2264069T3 (da) 2004-02-24 2005-02-12 Rensning af fibrinogen

Country Status (11)

Country Link
US (1) US7550567B2 (da)
EP (3) EP2267025B1 (da)
JP (2) JP4965805B2 (da)
KR (1) KR101195777B1 (da)
AT (1) ATE509030T1 (da)
AU (1) AU2005200635B2 (da)
CA (1) CA2497796C (da)
DE (1) DE102004009400A1 (da)
DK (3) DK2267025T3 (da)
ES (3) ES2409888T3 (da)
PL (2) PL1568709T3 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
EP1950225A1 (de) * 2007-01-25 2008-07-30 Octapharma AG Verfahren zur Steigerung von Proteinausbeuten
WO2008102469A1 (ja) * 2007-02-23 2008-08-28 Kwansei Gakuin Educational Foundation 蛋白質結晶化剤および蛋白質結晶化剤を用いた蛋白質結晶化方法
CN101678086B (zh) * 2007-03-22 2013-07-10 财团法人化学及血清疗法研究所 固体纤维蛋白原制剂
FR2920429B1 (fr) * 2007-08-30 2012-10-05 Lfb Biotechnologies Procede de purification du facteur viii et du facteur von willebrand
EP2077118A1 (en) * 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Clottable concentrate of platelet growth factors and preparation method thereof
EP2293776B8 (de) * 2008-06-23 2016-05-11 Bio-Products & Bio-Engineering Aktiengesellschaft Lagerstabiles, funktionell intaktes virus-inaktiviertes fibrinogen
US20100086529A1 (en) * 2008-10-08 2010-04-08 Mohammad Syed F Methods of making concentrated fibrinogen- and platelet-containing compositions
US8314211B2 (en) * 2009-04-07 2012-11-20 George Falus Tissue sealant for use in non compressible hemorrhage
IL213864A0 (en) * 2011-06-30 2011-08-31 Omrix Biopharmaceuticals Ltd Method for removing a lytic enzyme from a heterogeneous mixture
AU2013231321B2 (en) 2012-03-13 2017-05-25 Octapharma Ag Improved process for production of fibrinogen and fibrinogen produced thereby
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
SG10201911709RA (en) * 2012-12-05 2020-01-30 Csl Behring Gmbh A method of purifying therapeutic proteins
US20140154233A1 (en) * 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
CN104148037A (zh) * 2014-08-08 2014-11-19 华东理工大学 一种精氨酸键合型亲水色谱固定相及制备方法
US9932388B2 (en) 2014-11-13 2018-04-03 Hemarus Therapeutics Limited Chromatographic process for producing high purity fibrinogen and thrombin
KR101841587B1 (ko) 2016-01-12 2018-05-14 주식회사 녹십자홀딩스 피브리노겐의 정제방법
AU2017235870B2 (en) 2016-03-17 2023-02-23 Perkinelmer Health Sciences B.V. Detection of cells in a liquid sample
WO2018007767A1 (fr) * 2016-07-06 2018-01-11 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Fibrinogène liquide stable
FR3053592B1 (fr) * 2016-07-06 2020-05-29 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Fibrinogene liquide stable
EP3556728A1 (en) * 2018-04-16 2019-10-23 Croda Denmark A/S Organically modified mineral micro-particles, methods of preparing the same and uses thereof
CN114901685A (zh) 2019-12-10 2022-08-12 生物测试股份公司 用于制备纤维蛋白原制剂的方法
CN111848783B (zh) * 2020-07-29 2023-07-04 同路生物制药有限公司 一种人纤维蛋白原的制备方法
WO2023129802A1 (en) 2021-12-30 2023-07-06 Baxter International Inc. Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4170590A (en) * 1974-12-14 1979-10-09 Biotest-Serum-Institut Gmbh Ion exchanger treatment of citrate-stabilized plasma
US4188318A (en) 1975-06-16 1980-02-12 Edward Shanbrom Simplified method for preparation of high yield, high purity Factor VIII concentrate
NZ180199A (en) * 1976-03-04 1978-11-13 New Zealand Dev Finance Method of testing for the presence of elevated plasma liprotein concentration
CA1054052A (en) 1976-08-14 1979-05-08 Edward Shanbrom Simplified method for preparation of high yield, high purity factor viii concentrate
DE2903131A1 (de) 1978-02-06 1979-08-09 Biotest Serum Institut Gmbh Verfahren zur herstellung eines antihaemophilen globulin a enthaltenden konzentrats neben einem prothrombin-komplex und einer loesung von lagerstabilen serumproteinen
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4210580A (en) 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
DE3230849A1 (de) * 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung
DE3432083A1 (de) 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
US5043428A (en) 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
DE3670960D1 (de) * 1985-02-04 1990-06-13 Hoffmann La Roche Adsorbens fuer die reinigung von proteinen.
DE3734923C1 (de) * 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt
FR2632309B1 (fr) 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
US5094960A (en) 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
DE3904354A1 (de) 1989-02-14 1990-08-16 Behringwerke Ag Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung
US5169936A (en) 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
US5138034A (en) 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
DE3926539A1 (de) 1989-08-11 1991-02-14 Braun Melsungen Ag Verwendung von tentakel-kationenaustauschern zur selektiven eliminierung von low-density-lipoproteinen (ldl), fibrinogen und/oder harnstoff aus fluessigkeiten
JP2887329B2 (ja) * 1991-09-05 1999-04-26 バクスター インターナショナル インク 局所用フィブリノーゲン複合体
FR2686883B1 (fr) 1992-02-04 1994-05-13 Aquitaine Develop Transf Sanguin Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant.
US5259971A (en) 1992-03-02 1993-11-09 Cryolife, Inc. Method of preparing fibrinogen
US5639940A (en) 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
AU695266B2 (en) 1994-03-18 1998-08-13 Baxter International Inc. Topical fibrinogen complex
ES2139227T5 (es) 1994-07-14 2011-05-04 Caf-Dcf Département Central De Fractionnement De La Croix Rouge S.C.R.L. Concentrado de fibrinógeno obtenido de plasma sanguíneo, procedimiento e instalación para su preparación.
US5510102A (en) 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
US5723579A (en) 1996-02-02 1998-03-03 Bayer Corporation Fibrinogen binding peptides
US6037457A (en) 1997-01-31 2000-03-14 The University Of North Carolina At Chapel Hill Method for recombinant fibrinogen production
US5876947A (en) 1997-07-25 1999-03-02 The New York Blood Center, Inc. Monospecific antibody reactive with Fibrinogen and fibrinopeptide B
EP1026172A4 (en) * 1997-10-23 2003-05-07 Fujimori Kogyo Co METHOD FOR CLEANING THROMBINE SUBSTRATES AND / OR INHIBITORS OR METHOD FOR ELIMINATING THEM
KR100589082B1 (ko) 1998-01-23 2006-06-13 씨에스엘 리미티드 피브리노겐 정제
US5783663A (en) 1998-01-23 1998-07-21 Bayer Corporation Peptide ligands for affinity purification of fibrinogen
GB9807464D0 (en) 1998-04-07 1998-06-10 Pharming Bv Purification of human acid µ-glucosidase
WO2000017239A1 (en) 1998-09-24 2000-03-30 Ppl Therapeutics (Scotland) Limited Purification of fibrinogen from fluids by precipitation and hydrophobic chromatography
ATE321775T1 (de) 1998-09-24 2006-04-15 Pharming Intellectual Pty Bv Reinigung von fibrinogen aus milch durch den einsatz von kationenaustauschchromatographie
WO2001027623A2 (en) 1999-10-08 2001-04-19 V.I. Technologies, Inc. Isoagglutinin-depleted blood compositions and methods of making same
WO2001048016A1 (en) 1999-12-23 2001-07-05 Csl Limited Separation of fibrinogen from plasma proteases
WO2002095019A1 (en) 2001-05-21 2002-11-28 Omrix Biopharmaceuticals S.A. Removal of plasmin(ogen) from protein solutions
IL161262A0 (en) * 2001-10-03 2004-09-27 Christopher J Woolverton Storage-stable human fibrinogen solutions
GB0216001D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition

Also Published As

Publication number Publication date
KR101195777B1 (ko) 2012-11-05
EP2267025A3 (de) 2011-05-04
JP4965805B2 (ja) 2012-07-04
DK2267025T3 (da) 2015-07-20
DE102004009400A1 (de) 2005-09-08
JP2012051947A (ja) 2012-03-15
EP2267025B1 (de) 2015-05-13
AU2005200635A1 (en) 2005-09-08
AU2005200635B2 (en) 2011-11-10
CA2497796C (en) 2016-03-29
PL1568709T3 (pl) 2011-09-30
CA2497796A1 (en) 2005-08-24
EP2264069A2 (de) 2010-12-22
DK2264069T3 (da) 2013-07-15
PL2267025T3 (pl) 2015-10-30
EP1568709B1 (de) 2011-05-11
EP2264069A3 (de) 2011-05-04
KR20060043134A (ko) 2006-05-15
US7550567B2 (en) 2009-06-23
EP1568709A2 (de) 2005-08-31
US20050197493A1 (en) 2005-09-08
ES2365241T3 (es) 2011-09-27
JP2005239719A (ja) 2005-09-08
JP5713880B2 (ja) 2015-05-07
ATE509030T1 (de) 2011-05-15
ES2544456T3 (es) 2015-08-31
EP2267025A2 (de) 2010-12-29
EP1568709A3 (de) 2005-11-02
EP2264069B1 (de) 2013-04-17
ES2409888T3 (es) 2013-06-28

Similar Documents

Publication Publication Date Title
DK1568709T3 (da) Oprensning af fibrinogen
EA200800083A1 (ru) Способы очистки антител к бета-амилоиду
ATE363491T1 (de) Reinigung von antikörpern durch protein a und ionenaustauschromatographie
EA200702346A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ]БЕНЗОЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ЕЁ ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
WO2010048192A3 (en) Viral inactivation during purification of antibodies
CR8996A (es) PRODUCCION DE a-BETA
DK1527097T3 (da) Fremgangsmåde til rensning af preproinsulin
EA200700094A1 (ru) Способ промышленной очистки образцов клеток для получения терапевтических протеинов
AR062570A1 (es) Proceso para la purificacion de las proteinas que contienen fc
FR2737730B1 (fr) Procede de purification de virus par chromatographie
ATE468016T1 (de) Verwendung bestimmter alkoholalkoxylate als adjuvans für den agrotechnischen bereich
CO2022017780A2 (es) Proteínas inmunomoduladoras inhibidoras de april y baff y métodos de uso de las mismas
RS51512B (sr) Postupak za prečišćavanje interferonskih proteina pomoću katjonske izmenjivačke hromatografije
BRPI0507886A (pt) método de purificação de albumina compreendendo uma etapa de nanofiltração, solução e composição para uso terapêutico contendo-o
DK1519944T3 (da) Fremgangsmåder til fremstilling af fibrinogen
DK1399551T3 (da) Fremgangsmåde til oprensning af bakterieceller og cellebestanddele
ATE432946T1 (de) Abtrennung von fibrinogen von plasmaproteasen
RU2013127275A (ru) СПОСОБ СНИЖЕНИЯ И/ИЛИ УДАЛЕНИЯ FXI И FXIa ИЗ РАСТВОРОВ, СОДЕРЖАЩИХ УКАЗАННЫЕ ФАКТОРЫ СВЕРТЫВАНИЯ
ATE252592T1 (de) Verfahren zur reinigung von 2-keto-l-gulonic säure
AR045836A1 (es) Proceso para preparar y purificar mesotriona
ATE454471T1 (de) Neuartige pufferformulierungen zur isolierung, reinigung und rückgewinnung lang- und kurzkettiger nukleinsäuren
EA200600102A1 (ru) Очистка вариантов her-2
SE0201207D0 (sv) A process for production of a regioselective membrane
MX2023011371A (es) Purificacion de anticuerpos mediante cromatografia de modo mezclado.
ATE468343T1 (de) Verfahren zur reinigung von tacrolimus